| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |